LIVE POLIO IRUS VACCINES

INDEX
Abad Gómez, Héctor, 369
Abortion, see Fetal loss
"Acid barrier," see pH
Acid media, see pH marker
Adenoviruses
in cold mutant study population, 107
isolated, Costa Rica, 575
isolation from monkey feces, 77
occurrence before vaccination, 537
proposed using HeLa cells to prepare live vaccine,
599
vaccine contaminated with Simian agents, 79, 85
Types 1-7
vacuolating virus contaminant, 80
Adsorption marker
and covariation, 49
rate determination, 45
Africa, southern,
field trial, 474-479
African green monkeys (Cercopithecus aethiops),
see also Grivet, Vervet
cytopathic changes by vacuolating agent, 79
from east Africa, 88
African swine fever
tolerance study feasibility, 328
Agammaglobulinemia
immunological anomalies, 461
Agar extract,
M+ revertant, 199
Age
conversion rate by types, 116
distribution of antibody, 253, 440
distribution of cases, 453, 466-467, 559
early immunization advised, 270
economic status, 158
infection, transmission, 188
intensity of contact infection, 485
of study population, 114
response, 247, 294, 336
spread, 7
susceptibility, 411
susceptibility of young adults, 461, 500
susceptibility under 5 years, 182
vaccine failures, 373
vaccinated groups, 242, 277, 389-390, 436-437, 548
Agol, V. I., 44
Ainbender, Eugene A., paper 41-43
Alajuela province, Costa Rica
vaccination program, 1960, 563
Aland archipelago, Finland
map, description, 533-534
Alaska, heterotypic response, 122
Alba, Rafael Alvarez
see Alvarez Alba, Rafael
Albania
vaccine supplied by USSR, 419, 582
Alcocer, Juan José, paper 547-560; 532, 574
Alexander, E. Russell, 457
607
Alimentary tract
immunologic resistance of cells, 414, 421, 585
infection and response failure, 148
infection in 50 Costa Rican families, 174
no antibodies despite infection, 232
vaccine stability after passage, 6
All-Union Scientific Conference on Live Vaccine
countries represented, list, 581
Alma Ata, Kazakh SSR
age-scope of program, 581
laboratory diagnosis substantiated, 420
Altamarino, Nympha, 226
Aluminum hydroxide gel suspensions
adsorption and elution of Type 1 polio, 45
Alvarez, Manuel Ramos, see Ramos Alvarez, Manuel
Alvarez Alba, Rafael, paper, 386-409
Alvarez Amézquita, J., paper, 377-385
American Public Health Association Meeting
practicability of large-scale programs, 435
Amézquita, J. Alvarez, see Alvarez Amézquita. J.
Ancienne Cité, Leopoldville, Congo
number of vaccinee cases exceeded non-vaccinee
cases, 466
Anderson, Gaylord W., 4, 28, 30, 39, 44, 45, 47, 49,
50, 371, 411, 459-461
Animal virulence
correlation with human virulence, 444
Anthrax
experimental method in chickens, 35
Antibodies
abortive infection, 159
after fetal loss, 372
against vacuolating agent, 84-85
avidity, 268
development and persistence, 207, 228-239, 381, 417
distribution by age, 278
distribution in children, 281
dose relationship, 98
estimation and quality in evaluation, 121, 228, 238,
269, 373, 512
heterotypic
appearance and persistence, 232, 235
standards for measurement, 602
Type 2 and 3 with Type 1 vaccination, 540
homotypic, 363
standards for measurement, 602
in children fed CHAT and Fox, 530
in human milk, 325
in infants, 218
in seronegatives, 348-349
low avidity and virus-antibody dissociation, 268
maternal antibodies
and infant susceptibility, 306
and intestinal infection in vaccinated infant, 6,
288, 305, 308
effect on vaccination, 197, 219, 287, 294-295, 304,
326, 329